Direxion Daily S&P Biotech Bull 3X ETF
LABU
43 hedge funds and large institutions have $51.9M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2024 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 7 increasing their positions, 17 reducing their positions, and 8 closing their positions.
75% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 8
60% more call options, than puts
Call options by funds: $123M | Put options by funds: $77.1M
16% more funds holding
Funds holding: 37 → 43 (+6)
0.13% more ownership
Funds ownership: 5.34% → 5.48% (+0.13%)
9% less capital invested
Capital invested by funds: $56.8M → $51.9M (-$4.89M)
59% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
QC
Quadrature Capital
London,
United Kingdom
|
+$9.41M |
| 2 |
TI
Tidal Investments
Milwaukee,
Wisconsin
|
+$9.13M |
| 3 |
CM
Cercano Management
Bellevue,
Washington
|
+$3.75M |
| 4 |
GS
GTS Securities
Miami,
Florida
|
+$868K |
| 5 |
Jane Street
New York
|
+$799K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$7.7M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$7.31M |
| 3 |
HF
HRT Financial
New York
|
-$7.23M |
| 4 |
TAA
TB Alternative Assets
Grand Cayman,
Cayman Islands
|
-$4.57M |
| 5 |
Squarepoint
New York
|
-$3.05M |
LABU Hedge Fund Activity: Q3 2024 in Review
43 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q3 2024, worth a combined $51.9M — down 8.6% from $56.8M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new LABU positions and 8 closed out — a net gain of 6 holders — while 7 added to existing stakes and 17 trimmed.
The largest buyer was Quadrature Capital, opening a new position worth an estimated $9.41M. The largest seller was Bank of America, cutting an estimated $7.7M.
- 43 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q3 2024, up from 37 in Q2 2024.
- Funds reported $51.9M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q3 2024, down 8.6% quarter-over-quarter.
- 14 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q3 2024 and 8 closed out, a net change of +6 holders.
- The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q3 2024 was Quadrature Capital, an estimated $9.41M added.
- The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q3 2024 was Bank of America, an estimated $7.7M sold.
Based on aggregated 13F filings for Q3 2024.